PROCEPT BioRobotics Corporation (PRCT)
$19.57+6.36%Close
SELLRECOVERY · day 2
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1.1B
- Beta
- 0.90
- P/E (TTM)
- -9.03
- Short % float
- 13.60%
- Days to cover
- 5.3
- SI change
- -0.2%
- 1W
- +9.82%
- 1M
- -3.97%
- vs SPY 1W
- +9.40%
- vs SPY 1M
- -6.04%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on PRCT?
- LOPJLB’s latest quantitative signal on PROCEPT BioRobotics Corporation (PRCT) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is PRCT in?
- PROCEPT BioRobotics Corporation (PRCT) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does PROCEPT BioRobotics Corporation (PRCT) do?
- PROCEPT BioRobotics Corporation specializes in pioneering surgical robotic technologies, offering innovative solutions within the field of urology. Its flagship product is the AquaBeam Robotic System, a sophisticated, image-guided surgical robot designed for minimally invasive urological procedures. This system primarily facilitates Aquablation therapy, which the company also devised, to allevi…